Study Stopped
structural change at the hospital
Evaluation of Physical Exercise to Prevent Functional Deterioration During Hospitalization (EFFAPRO)
EFFAPRO
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This is a randomized study that will measure the possible benefit of supervised training during the hospitalization of patients with stage IV neoplasms in active treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2018
CompletedStudy Start
First participant enrolled
August 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 28, 2018
CompletedFirst Posted
Study publicly available on registry
March 16, 2022
CompletedMarch 16, 2022
March 1, 2022
Same day
August 27, 2018
March 4, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional capacity
Functional Independence Measure (FIM)
Through study completion (average 10 days)
Secondary Outcomes (8)
Strength
Through study completion (average 10 days).
Cardiorespiratory condition
Through study completion (average 10 days)
Daily physical activity
Through study completion (average 10 days)
Fatigue-FACIT
Through study completion (average 10 days)
Fatigue-PERFORM
Through study completion (average 10 days)
- +3 more secondary outcomes
Study Arms (2)
Supervised physical exercise
EXPERIMENTALSupervised exercise (aerobic + strength + flexibility) depending on the functional capacity of each patient, during hospitalization
Control
NO INTERVENTIONPatients will receive recommendations about exercising during hospitalization.
Interventions
A supervised exercise is randomized. Although this intervention is not standard in our setting, it is a recommended practice, since it is known that rehabilitation strategies in hospitalized patients have different benefits.
Eligibility Criteria
You may qualify if:
- Patients with stage IV neoplasms.
- Active treatment: chemotherapy, hormone therapy, immunotherapy or targeted therapies.
- Hospitalization at Medical Oncology Departmentof the Hospital Puerta de Hierro.
- Reason for hospitalization is expected to be solved in less than two weeks.
You may not qualify if:
- Patients who do not wish to participate.
- Cognitive impairment.
- Hospitalization due to progression of oncological disease.
- Acute coronary syndrome or bone fracture in limbs during the previous three months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario Puerta de Hierro
Majadahonda, Madrid, 28222, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ana Ruiz Casado
Puerta de Hierro University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Oncologist
Study Record Dates
First Submitted
August 27, 2018
First Posted
March 16, 2022
Study Start
August 28, 2018
Primary Completion
August 28, 2018
Study Completion
August 28, 2018
Last Updated
March 16, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share